Jane Street
WHWK

Jane Street’s Whitehawk Therapeutics WHWK Stock Holding History

Jane Street’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
+20,000
New +$62.6K ﹤0.01% 10829

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Jane Street's WHWK Position: Q1 2026 in Review

Jane Street increased its Whitehawk Therapeutics (WHWK) stake by 116% in Q1 2026, buying an estimated $254K and bringing the position to 151,110 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #7958.

Jane Street first reported a position in WHWK in Q3 2018 and has held it in 17 quarters since. The position peaked at $683K in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Jane Street held 151,110 shares of Whitehawk Therapeutics worth $521K as of Q1 2026.
  • Jane Street bought 81,179 Whitehawk Therapeutics shares in Q1 2026, an estimated $254K.
  • Whitehawk Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7958 holding.
  • Jane Street first reported a position in Whitehawk Therapeutics in Q3 2018 and has held it in 17 quarters since.
  • Jane Street's Whitehawk Therapeutics position peaked at $683K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.